Learn More
Medchemexpress LLC Purinostat mesylate | 2650188-32-0 | 99.5% | 586.62 | 25 MG

Supplier: Medchemexpress LLC 25MGHY150109
Purinostat mesylate is a selective inhibitor of HDAC. It inhibits class I and class IIb HDACs with IC50s ranging from 0.81 to 11.5 nM. It induces apoptosis and affects the cell cycle of LAMA84 and 188 BL-2 cells, showing potent anti-leukemia effects in vivo. It is used for research on lymphoblastic leukemia.
- Inhibits class I and class IIb HDACs
- Induces apoptosis and affects cell cycle of LAMA84 and 188 BL-2 cells
- Suppresses leukemia progression in vivo
- Demonstrates potent anti-leukemia effects in BCR-ABL(T315I)-induced primary B-ALL mice
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.